DR. SELLS VEJ 16 ApS: Financial statements 2022
CVR: 26671132
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
DR. SELLS VEJ 16 ApS (CVR 26671132) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 10,648 and a net result of DKK -57,317 compared with DKK 61,942 the year before. That is a decrease of 84.8% compared with the year before. Equity in the 2022 report amounted to DKK 619,821. The solvency ratio was 95%.
- Gross Profit
- DKK 10,648
- Profit/Loss
- DKK -57,317
- Equity
- DKK 619,821
- Total Assets
- DKK 652,152
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 11K | -57K | 620K | - |
| 2021 | - | 70K | 62K | 977K | - |
| 2020 | - | 70K | 60K | 915K | - |
| 2019 | - | 70K | 60K | 855K | - |
| 2018 | - | 71K | 58K | 795K | - |
Official annual report
Keep an eye on DR. SELLS VEJ 16 ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of March 23, 2022, Lone Bille Tams is registered as director of DR. SELLS VEJ 16 ApS.
As of March 23, 2022, Povl Pedersen has stepped down as director of DR. SELLS VEJ 16 ApS.
DR. SELLS VEJ 16 ApS has published its annual report for 2021. Gross profit came to DKK 70,090, and the net result was DKK 61,942.
About DR. SELLS VEJ 16 ApS
DR. SELLS VEJ 16 ApS was a Danish company of the type Anpartsselskab based in Slagelse, founded in 2002. The company has been dissolved on 29 May 2024. The company was registered under the industry Anden finansiel formidling undtagen forsikring og pensionsforsikring, i.a.n.. In 2023, the company reported a gross profit of DKK 7,209 and a net result of DKK 25,965 compared with DKK -57,317 the year before. Equity in the 2023 report amounted to DKK 645,785.
